The world’s largest superconducting magnet machinery company is aiming for an IPO

May 19, 2025  Source: drugdu 77

"/Recently, according to the official website of the Shanghai Stock Exchange, the IPO application of Ningbo Jianxin Superconducting Technology Co., Ltd. (hereinafter referred to as Jianxin Superconducting) on the Science and Technology Innovation Board has been accepted. It is worth mentioning that the company has become the third company to be accepted on the Science and Technology Innovation Board in 2025.
According to the prospectus, Jianxin Superconducting is mainly engaged in the research and development, production and sales of core components of medical magnetic resonance imaging (MRI) equipment. The company was founded in 2013. After years of development in the MRI industry, its main products are now widely deployed in the MRI field, including superconducting magnets, permanent magnets and gradient coils. In addition, Jianxin Superconducting has mastered a number of core technologies in the MRI field and is committed to implementing the technology.

It is worth mentioning that Jianxin Superconducting is currently the world's largest independent superconducting magnet supplier, and has broken the long-term monopoly of foreign brands. Its MRI equipment ranks fifth in the global market share and second among local companies. According to the prospectus, it has many customers, including medical device giants: GE Healthcare, United Imaging Healthcare, etc.

At present, in the field of superconductivity, Jianxin Superconducting has formed a rich product matrix including 1.5T zero volatility superconducting magnets, 1.5T liquid helium-free superconducting magnets, 3.0T zero volatility superconducting magnets and open zero volatility superconducting magnets. The 1.5T liquid helium-free superconducting magnet developed by it has Jianxin Superconducting's original technology-all-solid-state conduction cold technology. This product is the first in the world to realize the complete liquid helium-free superconducting magnet.

Jianxin Superconducting is also well-known in the field of permanent magnets. At present, the company is the world's largest supplier of permanent magnets for MRI equipment. Based on the company's own unique technology, it provides customers around the world with a rich series of high-quality permanent magnet products.

Based on a series of original technologies and excellent products, Jianxin Superconducting's revenue performance in recent years has also been quite remarkable. Although the revenue in 2024 has declined slightly compared with 2023, Jianxin Superconducting explained in the prospectus that it was mainly due to the permanent magnet products being affected by the decline in the price of magnetic steel raw materials.

From its product revenue, we can see that the sales of superconducting products have increased year by year. Although the pace of performance growth has slowed down in 2024 due to factors such as pressure from centralized procurement and the implementation of medical equipment renewal policies, it has generally maintained its upward development momentum.


This time, Jianxin Superconducting intends to publicly issue no more than 41.92 million shares, not less than 25% of the total share capital after issuance. After deducting the issuance expenses, the funds raised will be used as follows:
MRI equipment, as one of the two heroes in medical imaging technology, is one of the most important imaging tools for clinical disease diagnosis and basic scientific research.

According to public data, the global MRI equipment market is currently maintaining a trend of sustained growth, and its market size has increased from US$7.5 billion in 2015 to US$11.1 billion in 2024. China 's MRI equipment market share also shows a rapid growth trend. In 2024, the market size has reached 16.6 billion yuan, and it is expected to reach 22.76 billion yuan in 2030.

Jianxin Superconducting's prospectus shows that the current major global MRI equipment manufacturers are: GE Healthcare, Siemens Healthcare, Philips Healthcare, United Imaging Healthcare and other companies. Among them, Siemens Healthcare occupies most of the global MRI superconducting magnet market and the Chinese MRI superconducting magnet market, and ranks among the top three in overseas markets with GE Healthcare and Philips Healthcare.
Although foreign brands still occupy the majority of the market share in China's MRI superconducting magnet market, with the continuous improvement of China's scientific and technological level and medical level, a number of medical device companies focusing on MRI technology have emerged in China , such as United Imaging Healthcare, Jianxin Superconducting, Neusoft Medical, etc. Among them, United Imaging Healthcare and Jianxin Superconducting have caught up, greatly accelerating the process of domestic substitution.

According to the query of the Medical Device Data-Marketing Device Screening System, China has currently approved the listing of nearly 200 magnetic resonance imaging series products. Among the approved products, superconducting magnetic resonance imaging systems are the largest in number, and the number of permanent magnet magnetic resonance imaging systems ranks second.
It is worth mentioning that among the nearly 200 magnetic resonance imaging products approved for marketing, domestic forces have already risen, with domestic products accounting for 90.63% and imported products accounting for only 9.37%.

At the same time, Chinese policies are also supporting localization. In March 2024, the "Action Plan for Promoting Large-Scale Equipment Updates and Consumer Goods Replacement" issued by the State Council clearly listed medical equipment updates as a key area; on December 5, 2024, the Ministry of Finance issued the "Notice on Matters Related to Domestic Product Standards and Implementation Policies in the Government Procurement Field (Draft for Comments)", pointing out that in government procurement activities, domestic products are given a 20% price review discount relative to non-domestic products.

Under multi-faceted development, domestic equipment has ushered in major benefits. As Chinese medical equipment companies that deploy MRI technology continue to innovate and develop, it is expected to achieve domestic substitution in this field as soon as possible.

Conclusion

From the perspective of product layout and revenue, Jianxin Superconducting's development momentum continues to improve. As the third company accepted in the Science and Technology Innovation Board this year, Jianxin Superconducting has attracted much attention. We look forward to Jianxin Superconducting's wonderful performance in the future.

https://news.yaozh.com/archive/45466.html

By editor
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.